Rachel Frank | executive |
Sanj Patel | executive |
Ross Moat | executive |
Mark Ragosa | executive |
Anupam Rama | analyst |
John Paolini | executive |
Eva Fortea-Verdejo | analyst |
Liisa Bayko | analyst |
Good day, and thank you for standing by. Welcome to Kiniksa Pharmaceuticals Second Quarter 2021 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I will now hand the conference over to your speaker for today, Rachel Frank, Head of Investor Relations. Please go ahead.